Skip to content

Optibrium vs Terray Therapeutics

Optibrium logo

Optibrium

elegant software that guides successful drug discovery

44 employees · est. 2009 · Cambridge, United Kingdom

VS
Terray Therapeutics logo

Terray Therapeutics

Everything small molecule drug discovery should be

142 employees · est. 2018 · Pasadena, United States

Optibrium is the older company (2009 vs 2018); Terray Therapeutics is the larger of the two.

Side-by-Side Comparison

Optibrium Terray Therapeutics
Founded
2009 older 2018
Headquarters
Cambridge, United Kingdom Pasadena, United States
Employees
44 142 larger
Industry
Biotechnology, Pharmaceutical AI, Biopharma, Biotechnology
Funding Stage
Growth Series B
Total Funding
$1.00M $195.00M
Funding Rounds
4 5
Services
AI-guided drug discovery, Real-time collaboration for molecular design, 3D ligand-based and structure-based design, Metabolism insights for DMPK scientists, Chemical discovery pipeline optimization AI and experimental hardware development for drug discovery, Creating custom datasets for pharmaceutical research, Drug design and development for small molecules
Target Customers
Pharmaceutical companies, Biotechnology firms, Medicinal chemists, DMPK scientists, R&D teams in chemical and drug discovery Biotechnology companies, Pharmaceutical firms, Research institutions, Healthcare organizations
Taxonomy
Drug Discovery SoftwareSmall Molecule DesignOptimisationStarDropPredictive ModellingAugmented Chemistry +7 Small Molecule Drug DiscoveryUltra-high Throughput ExperimentationGenerative AIMedicinal ChemistryNanotechnologyData-driven Drug Development +7
Website
optibrium.com terraytx.com
Optibrium logo

About Optibrium

Optibrium, founded in 2009 and headquartered in Cambridge, UK, offers software solutions that enhance the efficiency and productivity of small molecule drug discovery. With its flagship product, StarDrop™, Optibrium provides an integrated software suite delivering predictive modeling and decision-ma...

Terray Therapeutics logo

About Terray Therapeutics

Terray Therapeutics, founded in 2018, is an innovative biotechnology company dedicated to transforming small molecule drug discovery. Their slogan, "Everything small molecule drug discovery should be.", encapsulates their commitment to revolutionizing this space. The company leverages a powerful pl...

Also comparing in this category

Comparing more than these two?

Get Optibrium, Terray Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Optibrium compare?

A PDF of Optibrium and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Optibrium was founded in 2009, based in Cambridge, United Kingdom, with 44 employees. Optibrium, founded in 2009 and headquartered in Cambridge, UK, offers software solutions that enhance the efficiency and productivity of small molecule drug discovery. With its flagship product, StarD. Terray Therapeutics was founded in 2018, based in Pasadena, United States, with 142 employees. Terray Therapeutics, founded in 2018, is an innovative biotechnology company dedicated to transforming small molecule drug discovery. Their slogan, "Everything small molecule drug discovery should be.
Optibrium has raised $1.00M and Terray Therapeutics $195.00M. Latest stage: Optibrium Growth, Terray Therapeutics Series B.
Both work in Biotechnology and list medicinal chemistry among their focus areas.

Compare Optibrium with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Optibrium on 15 Jun 2026, and Terray Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout